Valneva SE, a specialty vaccine company, announced it will report its first quarter 2026 consolidated financial results on May 13, 2026. The company will host a live webcast at 3 p.m. CET/9 a.m. ET to discuss the results and provide a business update, accessible on its website. Valneva focuses on developing vaccines for infectious diseases, including a Lyme disease vaccine candidate partnered with Pfizer. This update is important for investors tracking the company's progress and vaccine pipeline development.
Alvotech announced that Celtic Lux Holdings S.a. r.l., formerly Alvogen Lux Holdings, pledged 88,940,619 shares and 7,007,321 Swedish warrants equivalent to shares on June 26. This transaction was reported to Luxembourg's financial regulator CSSF. Th...
Canada's federal government and British Columbia have signed the Cooperative Prosperity Agreement, aiming to unlock over $200 billion in new investments focused on natural resources like LNG, critical minerals, and infrastructure. Concurrently, Alber...
Crédit Agricole has increased its ownership in Banco BPM to 29.3%, surpassing the 25% threshold through market purchases and derivatives. This move reflects Crédit Agricole's commitment as a long-term investor supporting the Italian economy and stren...
A new phishing scam targets XRP users by distributing fake "reward" and "payout" NFTs that trick victims into authorizing transactions that drain their wallets. One victim lost about $15,000 after accepting a bogus "Ripple Payout Token" NFT, which ex...
BlackRock, Inc. notified Umicore on July 1, 2026, that its direct voting rights in the company fell below the 5% legal threshold on June 30, 2026. After the transaction, BlackRock holds 4.97% direct voting rights and 0.68% equivalent financial instru...
